Llwytho...
The Gut Microbiome and Response to Cardiovascular Drugs
The gut microbiome is emerging as an important contributor to both cardiovascular disease risk and metabolism of xenobiotics. Alterations in the intestinal microbiota are associated with atherosclerosis, dyslipidemia, hypertension and heart failure. The microbiota have the ability to metabolize medi...
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | Circ Genom Precis Med |
|---|---|
| Prif Awduron: | , |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
2019
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6751004/ https://ncbi.nlm.nih.gov/pubmed/31462078 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/CIRCGEN.119.002314 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|